What is the best treatment approach for a patient with depression and atrioventricular (AV) block?

Treatment of Depression in Patients with Atrioventricular Block

Primary Recommendation

For patients with depression and AV block, treat the AV block first according to its type and severity, then initiate depression treatment with selective serotonin reuptake inhibitors (SSRIs)—specifically sertraline—while avoiding tricyclic antidepressants (TCAs), which are contraindicated due to their cardiac conduction effects. 1, 2, 3

---

Step 1: Immediate Management of the AV Block

Assess AV Block Type and Severity

• First-degree AV block (PR >0.20 seconds): Generally benign and requires no treatment if asymptomatic and PR <0.30 seconds 1, 2, 4
• Mobitz Type I (Wenckebach): Permanent pacing indicated only if symptomatic and persistent 2
• Mobitz Type II: Permanent pacemaker implantation is indicated (Class I) regardless of symptoms due to high risk of progression to complete heart block 1, 2
• Third-degree (complete) AV block: Permanent pacing indicated for all symptomatic patients, asymptomatic patients with average awake ventricular rates <40 bpm, or those with cardiomegaly or LV dysfunction 2

Acute Symptomatic Bradycardia Management

• Atropine 0.5 mg IV every 3-5 minutes (maximum 3 mg total) is the first-line drug for acute symptomatic bradycardia at the AV nodal level 1, 4
• Use atropine cautiously in acute coronary ischemia or MI, as increased heart rate may worsen ischemia 1
• Atropine will be ineffective in Mobitz Type II or infranodal blocks 1
• If atropine fails or is contraindicated, consider dopamine and epinephrine as bridge therapy while arranging for pacemaker implantation 5

---

Step 2: Depression Treatment After AV Block Stabilization

First-Line Antidepressant Selection

Sertraline is the preferred antidepressant for patients with cardiac disease and AV block due to its low risk of drug-drug interactions, favorable adverse effect profile, and potential beneficial antiplatelet activity 3

Alternative SSRI Options

• Other SSRIs are relatively safe and effective in patients with cardiac disease 3, 6
• Avoid escitalopram in elderly patients with cardiac conduction abnormalities, as it can induce third-degree AV block and QT prolongation 7

Antidepressants to AVOID

• Tricyclic antidepressants (TCAs) are contraindicated in patients with AV block due to their quinidine-like effects on cardiac conduction, which can worsen AV block and cause QT prolongation 3
• Monoamine oxidase inhibitors (MAOIs) should be avoided due to orthostatic hypotension and cardiac risks 3
• Quetiapine (if considering augmentation) can induce third-degree AV block, particularly in elderly patients 7

Monitoring Requirements

• Obtain baseline ECG before initiating antidepressants to document PR interval and QRS duration 7
• Regular ECG monitoring is essential when prescribing SSRIs or SNRIs to minimize risk of malignant arrhythmia, particularly in elderly patients 7
• Monitor for QT prolongation with certain SSRIs (citalopram, escitalopram), SNRIs, and mirtazapine 3

---

Step 3: Consider Psychotherapy as Alternative or Adjunct

• Psychotherapy (particularly cognitive behavioral therapy) is effective for depression in cardiac patients and may be preferred in patients with heart failure 6
• Psychotherapy has beneficial effects on depression with less evidence of direct cardiac benefit compared to SSRIs 6
• Multimodal depression care management approaches that flexibly combine pharmacotherapy and psychotherapy based on patient needs show promise across cardiac patient groups 6

---

Step 4: Address Underlying Cardiac Disease

• Screen for depression in all cardiac patients, as depression doubles the risk for cardiovascular disease and mortality 1
• Depression treatment improves patient-centered outcomes such as depressive symptoms and quality of life in cardiac patients 1
• Refer to cardiac rehabilitation (Class I recommendation) for all eligible patients with acute coronary syndrome or post-PCI, as this addresses both cardiac disease and depression 1

---

Critical Pitfalls to Avoid

• Never use TCAs or MAOIs in patients with any degree of AV block due to worsening of cardiac conduction 3
• Do not delay pacemaker implantation for Mobitz Type II or third-degree AV block while attempting pharmacologic management 1, 2
• Avoid using atropine doses <0.5 mg, as this may paradoxically slow heart rate further 1
• Do not assume first-degree AV block is always benign—patients with PR ≥300 ms, coexisting bundle branch block, or neuromuscular diseases require close monitoring and cardiology referral 4, 8
• Exercise caution with AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin, amiodarone) in patients with pre-existing AV block 8

---

Special Populations

Patients with Neuromuscular Diseases

• Patients with myotonic dystrophy, Kearns-Sayre syndrome, or Emery-Dreifuss muscular dystrophy should receive permanent pacing even if asymptomatic due to unpredictable progression 2, 4, 8

Elderly Patients

• Elderly patients are at particularly high risk for drug-induced third-degree AV block with escitalopram and quetiapine 7
• Regular ECG monitoring is mandatory in this population 7

Patients at High Risk for Ventricular Arrhythmias

• Bupropion has the lowest risk for QT prolongation and may be considered in patients at high risk for ventricular arrhythmias 3